Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $110
إدوارد لايفساينس
Edwards Lifesciences Corporation EW | 0.00 |
Citigroup analyst Joanne Wuensch maintains Edwards Lifesciences (NYSE:
EW) with a Buy and raises the price target from $101 to $110.
